文献速递乳腺外科围术期管理与 ERAS

扩展版BRA评分对乳房重建术后1年假体相关结局的预测:聚焦皮瓣坏死

Evaluating Mastectomy Skin Flap Necrosis in the Extended Breast Reconstruction Risk Assessment Score for 1-Year Prediction of Prosthetic Reconstruction Outcomes.
PubMed 文献 · J Am Coll Surg · 2018-05-17

1年MSFN率为12.4%,年龄较大、吸烟、术后感染、高血压及使用阿司匹林者MSFN率显著更高。BRA评分扩展至术后1年并发症风险评估,其预测的风险因素与已发表研究一致。

要点

  • 1年MSFN率12.4%,假体取出率13.2%,感染率6.9%。
  • 年龄较大、吸烟、术后感染、高血压、使用阿司匹林与MSFN升高相关。
  • 化疗、放疗、糖尿病及血清肿对坏死率无统计学显著影响。

核心结论

  • BRA评分已扩展至组织扩张器置入后1年内的并发症风险评估。
  • 按BRA评分:Extended Length计算出的MSFN风险与已发表研究中特定合并症增加风险的结论一致,进一步验证了该风险计算器的扩展。

研究设计与样本

  • 研究类型为基于前瞻性院内数据库的队列分析,数据来源为2004—2015年假体乳房重建病例。
  • 主要终点为Ⅰ期组织扩张器置入后1年内MSFN的发生。
  • 研究目的是评估MSFN与患者特征的关系,以验证BRA评分。

主要发现

  • 1年平均并发症率:MSFN 12.4%、血清肿3.0%、感染6.9%、裂开/外露7.1%、假体取出13.2%。
  • 年龄较大、吸烟、术后感染、高血压及使用阿司匹林的患者MSFN率有统计学显著升高。
  • 新辅助或辅助化疗、放疗、糖尿病及血清肿形成对坏死率无统计学显著影响。

临床怎么用

  • 可将BRA评分:Extended Length用于假体乳房重建术前咨询,评估术后1年MSFN等并发症风险。
  • 对年龄较大、吸烟、高血压、使用阿司匹林及术后感染风险高的患者,应加强术前优化与术后监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rates of mastectomy for breast cancer treatment and immediate reconstruction continue to rise. With increasing scrutiny on outcomes and patient satisfaction, there is an impetus for providers to be more deliberate in appropriate patient selection for breast reconstruction. The Breast Reconstruction Risk Assessment (BRA) Score was developed for prediction of complications after primary prosthetic breast reconstruction, focusing on calculating risk estimations for a variety of complications based on individual patient demographic and perioperative characteristics. In this study, we evaluated mastectomy skin flap necrosis (MSFN) as a function of patient characteristics to validate the BRA Score. STUDY DESIGN: We examined our prospective intra-institutional database of prosthetic breast reconstructions from 2004 to 2015. The end point of interest was 1-year occurrence of MSFN after stage I tissue expander placement. RESULTS: Nine hundred and three patients were included; 50% underwent bilateral reconstruction. Median follow-up was 23 months. Mean 1-year complication rates were as follows: MSFN 12.4%, seroma 3.0%, infection 6.9%, dehiscence/exposure 7.1%, and explantation 13.2%. Statistically significantly higher rates of MSFN were found in older patients, smokers, patients with postoperative infections, patients with hypertension, and patients who used aspirin. Neoadjuvant or adjuvant chemotherapy and radiation, diabetes, and seroma formation did not have a statistically significant impact on necrosis rates. CONCLUSIONS: The BRA Score was expanded to estimate complication risk after tissue expander placement up to 1 year postoperatively. The risk of MSFN as calculated by the BRA Score: Extended Length is consistent with published studies demonstrating increased risk with specific comorbidities, and further validates expansion of the BRA score risk calculator.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Hansen N, Espino S, Blough JT, et al. Evaluating Mastectomy Skin Flap Necrosis in the Extended Breast Reconstruction Risk Assessment Score for 1-Year Prediction of Prosthetic Reconstruction Outcomes. J Am Coll Surg. 2018. PMID: 29778821. doi:10.1016/j.jamcollsurg.2018.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。